The Artificial Intelligence Sector

The sector of artificial intelligence includes not only the big players but also many startups ready to carve out their space in the market, focusing on specific niches. An example of this is represented by the new project of Miles Wang, a researcher from OpenAI who decided to leave the ChatGPT company to work on a new AI hardware product for a new project.

AI for Drug Discovery?

Miles Wang is a researcher specializing in using artificial intelligence to accelerate scientific and biological discoveries. His new project involves the founding of a startup focused on the development of artificial intelligence models for drug discovery.

The startup is expected to involve other researchers from OpenAI. The project would also involve Lightspeed, which could lead the funding round. Wang's goal is to raise approximately 200 million dollars in funding, with a company valuation of about 2 billion dollars. According to reports from TechCrunch, Wang's new startup is set to work on AI models that will help find new uses for existing drugs (a potentially much cheaper operation compared to developing a drug from scratch) and possibly for those that previously did not pass clinical trials.

In recent months, several similar startups have raised funds to initiate research aimed at developing new drugs. Therefore, this represents a new trend in the artificial intelligence sector that could become increasingly significant in the future.